Shares of CryoPort, Inc. (NASDAQ:CYRX) rose 9.6% during mid-day trading on Friday . The stock traded as high as $8.96 and last traded at $8.43. Approximately 606,303 shares traded hands during mid-day trading, an increase of 127% from the average daily volume of 267,312 shares. The stock had previously closed at $7.69.

Several equities analysts recently weighed in on the stock. Janney Montgomery Scott increased their price target on shares of CryoPort from $10.00 to $12.00 and gave the company a “buy” rating in a research report on Tuesday. Cowen and Company restated an “outperform” rating and set a $11.00 price target (up previously from $7.50) on shares of CryoPort in a research report on Tuesday, September 12th. Finally, Needham & Company LLC increased their price target on shares of CryoPort from $8.50 to $10.00 and gave the company a “buy” rating in a research report on Wednesday, August 30th.

The company’s market capitalization is $208.00 million. The firm’s 50-day moving average is $8.57 and its 200-day moving average is $5.24.

CryoPort (NASDAQ:CYRX) last posted its earnings results on Tuesday, August 8th. The company reported ($0.08) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.09) by $0.01. The company had revenue of $2.92 million for the quarter, compared to the consensus estimate of $2.84 million. CryoPort had a negative return on equity of 67.75% and a negative net margin of 102.89%. Equities research analysts forecast that CryoPort, Inc. will post ($0.72) EPS for the current year.

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Northern Trust Corp raised its stake in CryoPort by 105.0% during the 2nd quarter. Northern Trust Corp now owns 22,179 shares of the company’s stock valued at $109,000 after acquiring an additional 11,358 shares during the last quarter. BerganKDV Wealth Management LLC raised its stake in shares of CryoPort by 157.5% during the 2nd quarter. BerganKDV Wealth Management LLC now owns 25,750 shares of the company’s stock worth $127,000 after buying an additional 15,750 shares in the last quarter. D.A. Davidson & CO. raised its stake in shares of CryoPort by 16.6% during the 2nd quarter. D.A. Davidson & CO. now owns 137,000 shares of the company’s stock worth $674,000 after buying an additional 19,500 shares in the last quarter. EAM Investors LLC purchased a new position in shares of CryoPort during the 2nd quarter worth approximately $552,000. Finally, Vanguard Group Inc. raised its stake in shares of CryoPort by 96.9% during the 2nd quarter. Vanguard Group Inc. now owns 519,100 shares of the company’s stock worth $2,554,000 after buying an additional 255,519 shares in the last quarter. 12.05% of the stock is owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY NOTICE: “CryoPort, Inc. (CYRX) Stock Price Up 9.6%” was originally reported by Watch List News and is owned by of Watch List News. If you are viewing this piece of content on another publication, it was illegally stolen and republished in violation of international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.watchlistnews.com/cryoport-inc-cyrx-stock-price-up-9-6/1613851.html.

CryoPort Company Profile

Cryoport, Inc (Cryoport) is a provider of cryogenic logistics solutions to the life sciences industry through its purpose-built packaging, information technology and specialized cold chain logistics expertise. The Company provides logistics solutions for biologic materials, such as immunotherapies, stem cells, chimeric antigen receptors (CAR)-T cells, and reproductive cells for clients.

Receive News & Ratings for CryoPort Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.